A detailed history of Morgan Stanley transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Morgan Stanley holds 5,720,762 shares of EW stock, worth $431 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,720,762
Previous 6,550,472 12.67%
Holding current value
$431 Million
Previous $605 Million 37.61%
% of portfolio
0.03%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $49.5 Million - $77.8 Million
-829,710 Reduced 12.67%
5,720,762 $378 Million
Q2 2024

Oct 17, 2024

BUY
$84.3 - $94.31 $31.3 Million - $35 Million
371,410 Added 6.01%
6,550,472 $605 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $31.3 Million - $35 Million
371,410 Added 6.01%
6,550,472 $605 Million
Q1 2024

Oct 17, 2024

SELL
$72.54 - $95.56 $26.9 Million - $35.5 Million
-371,410 Reduced 5.67%
6,179,062 $590 Million
Q1 2024

Aug 16, 2024

BUY
$72.54 - $95.56 $5.14 Million - $6.78 Million
70,901 Added 1.16%
6,179,062 $590 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $5.14 Million - $6.78 Million
70,901 Added 1.16%
6,179,062 $590 Million
Q4 2023

Aug 16, 2024

SELL
$61.71 - $77.76 $27.3 Million - $34.4 Million
-442,311 Reduced 6.75%
6,108,161 $466 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $60.8 Million - $76.6 Million
-985,267 Reduced 13.89%
6,108,161 $466 Million
Q3 2023

Nov 15, 2023

SELL
$69.28 - $93.38 $41 Million - $55.3 Million
-592,418 Reduced 7.71%
7,093,428 $491 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $68.7 Million - $79.7 Million
844,484 Added 12.34%
7,685,846 $725 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $25.4 Million - $28.9 Million
-342,452 Reduced 4.77%
6,841,362 $566 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $58.4 Million - $74.8 Million
855,755 Added 13.52%
7,183,814 $536 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $5.49 Million - $7.16 Million
66,704 Added 1.07%
6,328,059 $523 Million
Q2 2022

Oct 27, 2022

BUY
$86.5 - $128.27 $262 Million - $388 Million
3,023,685 Added 93.39%
6,261,355 $595 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $262 Million - $388 Million
3,023,685 Added 93.39%
6,261,355 $595 Million
Q1 2022

Oct 27, 2022

SELL
$101.96 - $128.34 $308 Million - $388 Million
-3,023,685 Reduced 48.29%
3,237,670 $381 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $46.7 Million - $58.8 Million
-457,979 Reduced 12.39%
3,237,670 $381 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $32.3 Million - $39.7 Million
303,564 Added 8.95%
3,695,649 $479 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $349 Million - $416 Million
3,392,085 New
3,392,085 $384 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.